CONTEXT: Despite recent progress in describing the common neural circuitry of emotion and stress processing, the bases of individual variation are less well understood. Genetic variants that underlie psychiatric disease have proven particularly difficult to elucidate. Functional genetic variation of neuropeptide Y (NPY) was recently identified as a source of individual differences in emotion. Low NPY levels have been reported in major depressive disorder (MDD). OBJECTIVE: To determine whether low-expression NPY genotypes are associated with negative emotional processing at 3 levels of analysis. DESIGN: Cross-sectional, case-control study. SETTING: Academic medical center. PARTICIPANTS: Among 44 individuals with MDD and 137 healthy controls, 152 (84%) had an NPY genotype classified as low, intermediate, or high expression according to previously established haplotype-based expression data. MAIN OUTCOME MEASURES: Healthy subjects participated in functional magnetic resonance imaging while viewing negative (vs neutral) words (n = 58) and rated positive and negative affect during a pain-stress challenge (n = 78). Genotype distribution was compared between 113 control subjects and 39 subjects with MDD. RESULTS: Among healthy individuals, negatively valenced words activated the medial prefrontal cortex. Activation within this region was inversely related to genotype-predicted NPY expression (P = .03). Whole-brain regression of responses to negative words showed that the rostral anterior cingulate cortex activated in the low-expression group and deactivated in the high-expression group (P < .05). During the stress challenge, individuals with low-expression NPY genotypes reported more negative affective experience before and after pain (P = .002). Low-expression NPY genotypes were overrepresented in subjects with MDD after controlling for age and sex (P = .004). Population stratification did not account for the results. CONCLUSIONS: These findings support a model in which NPY genetic variation predisposes certain individuals to low NPY expression, thereby increasing neural responsivity to negative stimuli within key affective circuit elements, including the medial prefrontal and anterior cingulate cortices. These genetically influenced neural response patterns appear to mediate risk for some forms of MDD.
CONTEXT: Despite recent progress in describing the common neural circuitry of emotion and stress processing, the bases of individual variation are less well understood. Genetic variants that underlie psychiatric disease have proven particularly difficult to elucidate. Functional genetic variation of neuropeptide Y (NPY) was recently identified as a source of individual differences in emotion. Low NPY levels have been reported in major depressive disorder (MDD). OBJECTIVE: To determine whether low-expression NPY genotypes are associated with negative emotional processing at 3 levels of analysis. DESIGN: Cross-sectional, case-control study. SETTING: Academic medical center. PARTICIPANTS: Among 44 individuals with MDD and 137 healthy controls, 152 (84%) had an NPY genotype classified as low, intermediate, or high expression according to previously established haplotype-based expression data. MAIN OUTCOME MEASURES: Healthy subjects participated in functional magnetic resonance imaging while viewing negative (vs neutral) words (n = 58) and rated positive and negative affect during a pain-stress challenge (n = 78). Genotype distribution was compared between 113 control subjects and 39 subjects with MDD. RESULTS: Among healthy individuals, negatively valenced words activated the medial prefrontal cortex. Activation within this region was inversely related to genotype-predicted NPY expression (P = .03). Whole-brain regression of responses to negative words showed that the rostral anterior cingulate cortex activated in the low-expression group and deactivated in the high-expression group (P < .05). During the stress challenge, individuals with low-expression NPY genotypes reported more negative affective experience before and after pain (P = .002). Low-expression NPY genotypes were overrepresented in subjects with MDD after controlling for age and sex (P = .004). Population stratification did not account for the results. CONCLUSIONS: These findings support a model in which NPY genetic variation predisposes certain individuals to low NPY expression, thereby increasing neural responsivity to negative stimuli within key affective circuit elements, including the medial prefrontal and anterior cingulate cortices. These genetically influenced neural response patterns appear to mediate risk for some forms of MDD.
Authors: C R Meyer; J L Boes; B Kim; P H Bland; K R Zasadny; P V Kison; K Koral; K A Frey; R L Wahl Journal: Med Image Anal Date: 1997-04 Impact factor: 8.545
Authors: C A Morgan; S Wang; S M Southwick; A Rasmusson; G Hazlett; R L Hauger; D S Charney Journal: Biol Psychiatry Date: 2000-05-15 Impact factor: 13.382
Authors: Ants Kask; Jaanus Harro; Stephan von Hörsten; John P Redrobe; Yvan Dumont; Rémi Quirion Journal: Neurosci Biobehav Rev Date: 2002-05 Impact factor: 8.989
Authors: J K Zubieta; Y R Smith; J A Bueller; Y Xu; M R Kilbourn; D M Jewett; C R Meyer; R A Koeppe; C S Stohler Journal: Science Date: 2001-07-13 Impact factor: 47.728
Authors: Jon-Kar Zubieta; Yolanda R Smith; Joshua A Bueller; Yanjun Xu; Michael R Kilbourn; Douglas M Jewett; Charles R Meyer; Robert A Koeppe; Christian S Stohler Journal: J Neurosci Date: 2002-06-15 Impact factor: 6.167
Authors: Charles A Morgan; Ann M Rasmusson; Sheila Wang; Gary Hoyt; Richard L Hauger; Gary Hazlett Journal: Biol Psychiatry Date: 2002-07-15 Impact factor: 13.382
Authors: Marta Peciña; Brian J Mickey; Tiffany Love; Heng Wang; Scott A Langenecker; Colin Hodgkinson; Pei-Hong Shen; Sandra Villafuerte; David Hsu; Sara L Weisenbach; Christian S Stohler; David Goldman; Jon-Kar Zubieta Journal: Cortex Date: 2012-02-14 Impact factor: 4.027
Authors: Kristen E Pleil; Alberto Lopez; Nora McCall; Ana M Jijon; Jose Peña Bravo; Thomas L Kash Journal: Neuropharmacology Date: 2011-12-09 Impact factor: 5.250
Authors: Ke Xu; Kwangik Adam Hong; Zhifeng Zhou; Richard L Hauger; David Goldman; Rajita Sinha Journal: Psychoneuroendocrinology Date: 2011-09-13 Impact factor: 4.905
Authors: Esther M Opmeer; Rudie Kortekaas; Marie-José van Tol; Nic J A van der Wee; Saskia Woudstra; Mark A van Buchem; Brenda W J H Penninx; Dick J Veltman; André Aleman Journal: Soc Cogn Affect Neurosci Date: 2013-03-11 Impact factor: 3.436
Authors: Andrei I Molosh; Tammy J Sajdyk; William A Truitt; Weiguo Zhu; Gerry S Oxford; Anantha Shekhar Journal: Neuropsychopharmacology Date: 2013-01-28 Impact factor: 7.853